Clinical Research Is Hard — And It’s Only Getting Harder
It takes 7-13 years to develop a new drug
95% of physicians don’t participate in clinical trials and 91% of patients are never invited to participate in a trial
85% of trials miss their targeted timelines
Trials have less than 15% minority representation on average
Some studies have as high as a 30% patient dropout rate
How can we improve research to better serve patients?
Only Elligo Health Research® Optimizes the Intersection of Healthcare and Research to Accelerate Clinical Trials
Elligo’s adaptive engagement model, consisting of PatientSelect®, SiteSelect, Research Partner Services, and our proprietary technology portfolio provides access to the best patients, healthcare experts, and research solutions.
As the ultimate healthcare-enabling research organization, we optimize the intersection of healthcare and research, maintain the integrity of the trusted patient-physician relationship, and leverage electronic health records to accelerate the development of new pharmaceutical, biotechnology, and medical device and diagnostic products while bringing more patients clinical research as a care option.
Challenge
It takes 7-13 years to develop a new drug
Only Elligo offers 4x trial acceleration
Challenge
95% of physicians don’t participate in clinical trials and 91% of patients are never invited to participate in a trial
Only Elligo has access to 150M+ patients and known physicians
Challenge
85% of trials miss their targeted timelines
Only Elligo offers end-to-end study workflow technology and support
Challenge
Trials have less than 15% minority representation on average
Only Elligo has 30%+ minority representation through non-traditional patient access
Challenge
Some studies have as high as a 30% patient dropout rate
Only Elligo has 28% higher patient retention
Challenge
It takes 7-13 years to
develop a new drug
Only Elligo offers 4x trial
acceleration
Challenge
95% of physicians don’t participate in clinical trials and 91% of patients are never invited to participate in a trial
Only Elligo has access to 150M+ patients and known physicians
Challenge
85% of trials miss their targeted timelines
Only Elligo offers end-to-end study workflow technology and support
Challenge
Trials have less than 15% minority representation on average
Only Elligo has 30%+ minority representation through non-traditional patient access
Challenge
Some studies have as high as a 30% patient dropout rate
Only Elligo has 28% higher patient retention
Customized Clinical Research Support
PatientSelect® Increases Patient Centricity and Access to Clinical Trials
Focusing on the patient healthcare journey, PatientSelect® offers direct access to more than 150 million known patients through HIPAA-compliant identified healthcare data and tailored services to optimize the intersection of healthcare and research and accelerate clinical trials.
SiteSelect Improves Site Performance Through Clinical Trial Services
SiteSelect optimizes site selection through our network of 600+ fully powered healthcare-first sites, Elligo-supported conventional sites, and study-specific site services.
Research Partner Services Empower Clinical Research Physicians
Research Partner Services provide a global clinical trials network and supportive technology, helping both new to research and experienced sites seamlessly participate in clinical trials.
Research-Enabling Technology for Clinical Data Management, Patient Recruitment, and Patient Retention
